July 21, 2017

July 21, 2017

Sen. John McCain's type of cancer did not slow Tampa woman
Tampa Bay Times – July 20
Unlike breast or colon cancer, there is no screening for glioblastoma, said Dr. Lodovico Balducci of the Moffitt Cancer Center in Tampa. "Unfortunately, the first thing is neurological symptoms," Balducci said.

Doctors see increase of rare cancer in older patients
Bay News 9 – July 20
However, Doctor Lodovico Balducci, the Director of the Senior/Adult Oncology Program at Moffitt Cancer Center, said he is seeing an increase of the rare cancer in older patients like McCain. “It's becoming more and more common in people ages 70 and older; in fact, there has been a sevenfold increase between the 50's and now," Balducci said.

Younger Age Predicts Node Positivity in T1 Melanoma
MedPage Today – July 20
In an accompanying editorial, Vernon Sondak, MD, of the Moffitt Cancer Center in Tampa, Fla., and colleagues, said, "The provocative observations in this article highlight the need for careful consideration of the indications for sentinel lymph node biopsy in patients with T1 and even T2a melanoma on an individualized basis, taking into account clinical factors, pathologic parameters, and, above all, patient preferences when making a decision about surgical staging of the regional lymph nodes."

South Seminole Heights neighborhood hopes street mural brings calm to the road
Tampa Bay Times – July 19
"I wanted to create a design that showed the vibrancy and energy of the neighborhood and at that same time was relatively easy to make because I knew children and parents would take a huge part in the painting of it," said Thomas, an artist in residence for Moffitt Cancer Center, helping patients heal through creating art, often, in her case, mandalas.

Rubio thanks House for passing cancer legislation
FloridaPolitics.com – July 19
The bill is supported by numerous cancer treatment providers around the country including the St. Jude’s Children’s Research Hospital, the Arnold Palmer Hospital, the Moffitt Cancer Center, the Harvard Medical School and many others. Also seen on SaintPetersBlog

Neoadjuvant Radiation Reduces Risk of Secondary Tumors in Early-Stage Breast Cancer
ASCO Post – July 18
Moffitt Cancer Center researchers conducted a first-of-its-kind study comparing the long-term benefits of radiation therapy in women with breast cancer in the neoadjuvant and adjuvant settings.

Immunotherapy Moves Into Rare Skin Cancer Type
Cure Magazine – July 17
Further, no one knows why some people develop it or why those without the virus develop MCC instead of melanoma or another skin cancer, says Jeffery Russell, M.D., Ph.D., an assistant professor of head and neck and cutaneous oncology at Moffitt Cancer Center in Tampa, Florida.

Emerging Agents Poised to Transform AML Landscape
OncLive – July 17
“We have to give the message to patients that there is more to offer,” said Jeffrey E. Lancet, MD, chair and program leader for the Department of Malignant Hematology, Moffitt Cancer Center. 

Challenges in the Treatment of CINV
OncLive – July 17
Dawn Dolan, PharmD, BCOP: That might be a little bit of a double-edged sword. We have these prebuilt order sets with what we think is the best antiemetic for a particular regimen, and that might make us a little bit more complacent in trying to hone in on specific patient risk factors and situations where we might need to tweak the regimen. 

Proteasome Inhibitors Paving Promising Path for Myeloma Treatment
OncLive – July 17
“There are lots of options, and so that’s not a problem—that's really a solution,” said Kenneth H. Shain, MD, of Moffitt Cancer Center. 

Radiation prior to surgery reduces risk of secondary tumors in early-stage breast cancer
Medical Xpress – July 17
Moffitt Cancer Center researchers launched a first of its kind study comparing the long-term benefits of radiation therapy in women with breast cancer either before surgery (neoadjuvant) or after surgery (adjuvant).

NETTER-1 Phase III Trial Results Meet Primary Endpoint
Oncology Tube – July 16
Jonathan R. Strosberg, MD of the H. Lee Moffitt Cancer Center discusses the Phase III trial results of NETTER-1 as reported by the New England Journal of Medicine.

Women: The New Faces of Mesothelioma
That persistence eventually led her to Dr. Sophie Dessureault, a gastrointestinal oncologist at the multidisciplinary Moffitt Cancer Center in Tampa. In 2013, Dessureault was the lead surgeon involved with Moffitt’s groundbreaking study detailing the benefits of the cytoreductive surgery and HIPEC combination as a treatment for peritoneal mesothelioma.


Please note we cannot guarantee the accuracy or availability of links. The stories belong to the respective publishers, and links may expire. Some news sites require you to register and select a password in order to retrieve articles, but most usually do not charge a fee to retrieve these news stories.